Hypoglycemia is common and dangerous in diabetes mellitus, so identifying at-risk patients may lead to useful preventive strategies. This Regenstrief-Merck partnership aims to design a risk calculator to aid clinicians in identifying at-risk patients who may benefit from preventive strategies. The project team members will conduct a retrospective cohort analysis, focus-group discussions, use of a new computer-based risk-prediction tool, and assessment of processes and outcomes associated with usage of the tool among healthcare providers.
-
Research
- Experts
In The News
View All
The Conversation featured Dr. Jill Inderstrodt
Jill Inderstrodt, PhD, MPH, was featured by The Conversation for...
Influence
View All
Effectiveness of 2023–2024 COVID-19 vaccines in children in the U.S.
Published in Pediatrics. Here is a link to the article....
- About
Regenstrief is dedicated to pioneering transformative solutions for a healthier world.
- The Latest
Partner With US - Experts
